• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

FMT in IBD: What Have We Learned?

作者信息

Kelly Colleen R, Allegretti Jessica R

机构信息

Miriam Hospital, and Lifespan Hospital System, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Division of Gastroenterology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Dig Dis Sci. 2017 Oct;62(10):2618-2620. doi: 10.1007/s10620-017-4713-9.

DOI:10.1007/s10620-017-4713-9
PMID:28840580
Abstract
摘要

相似文献

1
FMT in IBD: What Have We Learned?炎症性肠病中的粪菌移植：我们学到了什么？
Dig Dis Sci. 2017 Oct;62(10):2618-2620. doi: 10.1007/s10620-017-4713-9.
2
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.肠道微生物群、粪便微生物群移植与炎症性肠病
Gut Microbes. 2017 May 4;8(3):238-252. doi: 10.1080/19490976.2017.1290757. Epub 2017 Feb 10.
3
The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.粪便微生物群移植后炎症性肠病发作的风险：系统评价和荟萃分析。
Gut Microbes. 2017 Nov 2;8(6):574-588. doi: 10.1080/19490976.2017.1353848. Epub 2017 Sep 12.
4
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.炎症性肠病患者艰难梭菌感染的粪便微生物群移植结局
Dig Dis Sci. 2017 Oct;62(10):2870-2875. doi: 10.1007/s10620-017-4580-4. Epub 2017 Apr 27.
5
Role of fecal microbiota transplantation in inflammatory bowel disease.粪便微生物移植在炎症性肠病中的作用。
J Dig Dis. 2018 Jun;19(6):322-334. doi: 10.1111/1751-2980.12603. Epub 2018 May 29.
6
Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.炎症性肠病影响复发性艰难梭菌感染粪便微生物群移植的结果。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1433-8. doi: 10.1016/j.cgh.2016.02.018. Epub 2016 Feb 22.
7
Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?粪便微生物群移植作为炎症性肠病的治疗策略有未来吗？
Dig Dis. 2016;34 Suppl 1:74-81. doi: 10.1159/000447379. Epub 2016 Aug 22.
8
A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.两周粪便微生物群移植疗程在小儿炎症性肠病患者中的应用。
Adv Exp Med Biol. 2018;1047:81-87. doi: 10.1007/5584_2017_123.
9
Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.粪便微生物群移植对炎症性肠病患者复发性或难治性艰难梭菌感染安全有效。
Inflamm Bowel Dis. 2016 Oct;22(10):2402-9. doi: 10.1097/MIB.0000000000000908.
10
Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.炎症性肠病中粪便生物疗法的内镜下给药
Gastrointest Endosc Clin N Am. 2016 Oct;26(4):707-17. doi: 10.1016/j.giec.2016.06.006.

引用本文的文献

1
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights.炎症性肠病中的微生物群移植疗法：进展与机制洞察
Gut Microbes. 2025 Dec;17(1):2477255. doi: 10.1080/19490976.2025.2477255. Epub 2025 Mar 10.
2
Recent Research on Fecal Microbiota Transplantation in Inflammatory Bowel Disease Patients.炎症性肠病患者粪便微生物群移植的最新研究
Gastroenterol Hepatol (N Y). 2019 Jan;15(1):44-47.

本文引用的文献

1
Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.艰难梭菌感染复发患者行粪菌移植后微生物生态学的变化受潜在炎症性肠病的影响。
Microbiome. 2017 May 15;5(1):55. doi: 10.1186/s40168-017-0269-3.
2
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.炎症性肠病患者艰难梭菌感染的粪便微生物群移植结局
Dig Dis Sci. 2017 Oct;62(10):2870-2875. doi: 10.1007/s10620-017-4580-4. Epub 2017 Apr 27.
3
Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
炎症性肠病患者中使用粪便微生物群移植治疗复发性艰难梭菌感染
Gut Microbes. 2017 May 4;8(3):303-309. doi: 10.1080/19490976.2017.1279377. Epub 2017 Jan 19.
4
Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection.非达霉素治疗艰难梭菌感染的疗效
J Clin Gastroenterol. 2018 Feb;52(2):151-154. doi: 10.1097/MCG.0000000000000769.
5
Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.粪便微生物群移植对炎症性肠病患者复发性或难治性艰难梭菌感染安全有效。
Inflamm Bowel Dis. 2016 Oct;22(10):2402-9. doi: 10.1097/MIB.0000000000000908.
6
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.粪便微生物群移植对多次复发性艰难梭菌感染复发的影响：一项随机试验
Ann Intern Med. 2016 Nov 1;165(9):609-616. doi: 10.7326/M16-0271. Epub 2016 Aug 23.
7
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.欧洲临床微生物学和传染病学会：艰难梭菌感染诊断指南文件的更新。
Clin Microbiol Infect. 2016 Aug;22 Suppl 4:S63-81. doi: 10.1016/j.cmi.2016.03.010. Epub 2016 Jul 25.
8
Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.炎症性肠病患者艰难梭菌感染的流行病学、诊断及管理
Inflamm Bowel Dis. 2016 Jul;22(7):1744-54. doi: 10.1097/MIB.0000000000000793.
9
Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.入院时产毒艰难梭菌定植与感染风险：系统评价和荟萃分析。
Am J Gastroenterol. 2015 Mar;110(3):381-90; quiz 391. doi: 10.1038/ajg.2015.22. Epub 2015 Mar 3.
10
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.